Morteza Mahmoudi’s research while affiliated with Michigan State University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (432)


In vitro cytotoxicity assessment of anti-PLAC1-ADC. Prostate cancer cells and LS180, as negative cell control, were treated with at least 2.5 µg/mL anti-PLAC1 antibody or 2.5 µg/mL of anti-PLAC1-ADC, equivalent concentration of free SN38, or remained untreated. Cell morphology was visualized after 48 h under microscope (a). LNCaP cells were treated with different concentrations of free SN38 or equivalent concentrations of anti-PLAC1-ADC or isotype-matched-ADC and the rate of cell cytotoxicity was assessed by Calcein AM fluorometric assay. It is important to note that the highest concentration of antibody (10 µg/mL) was used in some control samples (e.g., DU145 cells) to confirm the absence of toxic effects on the cells, while the ADC treated cells at a concentration of 2.5 µg/mL exhibited clear toxicity. (b). Calcein AM-labeled LNCaP cells were inspected under fluorescent microscope 36 h after treatment with 2.5 µg/mL anti-PLAC1-ADC, isotype-matched-ADC, anti-PLAC1 antibody or equivalent concentration of free SN38 (c). IC50 values for free SN38 and anti-PLAC1-ADC were determined using the Prism software as described in materials and methods (d). Data were generated from four independent experiments. *Anti-PLAC1-ADC vs. free SN38, ϕanti-PLAC1-ADC vs. isotype-matched-ADC, * or ϕp < 0.05, ** or ϕϕp < 0.01, *** or ϕϕϕp < 0.001, **** or ϕϕϕϕp < 0.0001.
Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
  • Article
  • Full-text available

May 2025

·

22 Reads

Mohammad-Reza Nejadmoghaddam

·

Amir-Hassan Zarnani

·

·

[...]

·

Download


Protocol for 3D bioprinting of a 3D in vitro model of neuroblastoma

April 2025

·

14 Reads

·

1 Citation

STAR Protocols

Here, we present a protocol for developing an in vitro 3D model of neuroblastoma through bioprinting, incorporating key components of the tumor microenvironment (TME), including vasculature and cancer cell line spheroids. We describe steps for the preparation, bioprinting, and evaluation of tumor models and their use to assess the impact of TME on solid tumor behavior. We report procedures for bioink preparation, bioprinting, the measurement of mechanical properties and fidelity, as well as the viability of different cell types and their interactions. For complete details on the use and execution of this protocol, please refer to Ning et al.¹



Top-Down Proteomic Profiling of Protein Corona by High-Throughput Capillary Isoelectric Focusing-Mass Spectrometry

March 2025

·

5 Reads

·

1 Citation

Journal of the American Society for Mass Spectrometry

In the rapidly evolving field of nanomedicine, understanding the interactions between nanoparticles (NPs) and biological systems is crucial. A pivotal aspect of these interactions is the formation of a protein corona when NPs are exposed to biological fluids (e.g., human plasma), which significantly influences their behavior and functionality. This study introduces an advanced capillary isoelectric focusing tandem mass spectrometry (cIEF-MS/MS) platform designed to enable high-throughput and reproducible top-down proteomic analysis of protein corona. Our cIEF-MS/MS technique completed each analysis within 30 min. It produced reproducible proteoform measurements of protein corona for at least 50 runs regarding the proteoforms’ migration time [relative standard deviations (RSDs) <4%], the proteoforms’ intensity (Pearson’s correlation coefficients between any two runs >0.90), the number of proteoform identifications (71 ± 10), and the number of proteoform-spectrum matches (PrSMs) (196 ± 30). Of the 53 identified genes, 33 are potential biomarkers of various diseases (e.g., cancer, cardiovascular disease, and Alzheimer’s disease). We identified 1−102 proteoforms per potential protein biomarker, containing various sequence variations or post-translational modifications. Delineating proteoforms in protein corona by our cIEF-MS/MS in a reproducible and high-throughput fashion will benefit our understanding of nanobiointeractions and advance both diagnostic and therapeutic nanomedicine technologies.



Current traditional methods in different stages of cardio-oncology. ASCVD: Atherosclerotic Cardiovascular Disease; HFA-ICOS: Heart Failure Association - Cardio-Oncology Study; HS-CRP: High-Sensitivity C-Reactive Protein; FGF-23: Fibroblast Growth Factor 23; miRNA: MicroRNA; MPO: Myeloperoxidase; GDMT: Guideline-Directed Medical Therapy; HFSS: Heart Failure Survival Score; CMR: Cardiac Magnetic Resonance; LVEF: Left Ventricular Ejection Fraction; GLS: Global Longitudinal Strain
Applications of Al in cardio-oncology. CTR-CVD: Cancer treatment-related cardiovascular disease; GLS: Global longitudinal strain; LVEF: Left ventricular ejection fraction; QTc: Corrected QT Interval
End-user mapping: problems and AI solutions in Cardio-Oncology
Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review

February 2025

·

180 Reads

·

8 Citations

Current Cardiology Reports

Purpose of Review This review explores the role of artificial intelligence (AI) in cardio-oncology, focusing on its latest application across problems in diagnosis, prognosis, risk stratification, and management of cardiovascular (CV) complications in cancer patients. It also highlights multi-omics analysis, explainable AI, and real-time decision-making, while addressing challenges like data heterogeneity and ethical concerns. Recent Findings AI can advance cardio-oncology by leveraging imaging, electronic health records (EHRs), electrocardiograms (ECG), and multi-omics data for early cardiotoxicity detection, stratification and long-term risk prediction. Novel AI-ECG models and imaging techniques improve diagnostic accuracy, while multi-omics analysis identifies biomarkers for personalized treatment. However, significant barriers, including data heterogeneity, lack of transparency, and regulatory challenges, hinder widespread adoption. Summary AI significantly enhances early detection and intervention in cardio-oncology. Future efforts should address the impact of AI technologies on clinical outcomes, and ethical challenges, to enable broader clinical adoption and improve patient care.




Tailored Bioengineering and Nanomedicine Strategies for Sex-Specific Healing of Chronic Wounds

November 2024

·

40 Reads

·

1 Citation

British Journal of Dermatology

Chronic wounds, defined by their prolonged healing process, significantly impair patient quality of life and impose a hefty financial burden on healthcare systems worldwide. Sex/gender-specific mechanisms regulate inflammation and infection, angiogenesis, matrix synthesis, and cell recruitment contribute to cutaneous wound healing, but remain largely understudied. This review is aimed to spotlight the innovative realm of bioengineering and nanomedicine, which is at the helm of revolutionizing complex chronic wound care. It underscores the significance of integrating patient sex into the development and (pre)clinical testing of these avant-garde treatment modalities, in order to enhance healing prospects for both women and men. Moreover, we explore the representation of both sexes in clinical trials of bioengineered and nanomedicine products. Finally, we examine the primary reasons for the historical neglect in translating sex-specific wound healing research into clinical practice and propose strategic solutions. By tackling these issues, the article advocates for advanced treatment frameworks that could significantly improve healing outcomes for individuals of all sexes, thereby optimizing both efficacy and inclusivity in chronic wound management.


Citations (59)


... AI and advanced analytics offer a wide range of solutions to handle such high-dimensional data, providing sophisticated approaches to handle missing data, mitigating batch effects, and providing customizable solutions with various constraints through optimization algorithms [84]. AI methods can simulate multiple protein corona modulations to enhance deep proteome profiling of nanoparticles [85]. ...

Reference:

Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review
Small molecule modulation of protein corona for deep plasma proteome profiling

... However, the treated sample exhibited a significant signal corresponding to the small molecule after 60 min of separation time (Fig. 3b), validating our hypothesis that small molecules interact with plasma proteins, causing the observed variation in the protein corona on the NPs' surface. Furthermore, the process of recovering intact proteins from the surfaces of NPs primarily collects proteins from the outer layer of the protein corona 85 , as the inner layer is tightly bound to the NP surfaces through various physical and chemical forces 86 . This observation further confirms that PtdChos interacts with plasma proteins rather than directly with the NP surfaces, leading to the formation of its unique protein corona composition. ...

Mass Spectrometry-Based Top-Down Proteomics in Nanomedicine: Proteoform-Specific Measurement of Protein Corona
  • Citing Article
  • September 2024

ACS Nano

... Protein elution from the surface of NPs and purification were conducted based on procedures illustrated in our recent publications 85,100 . The protein corona-coated NPs (with/without PtdChos) were separately treated in a 0.4% (w/v) SDS solution at 60°C for 1.5 h with continuous agitation to release the protein corona from the NP surface. ...

Deciphering nanoparticle protein corona by capillary isoelectric focusing-mass spectrometry-based top-down proteomics

Chemical Communications

... This corona can significantly alter nanoparticle properties, including surface charge, hydrodynamic diameter, colloidal stability, and cellular interactions, ultimately affecting biodistribution, oxidative stress responses, and toxicity profiles [60,61]. Recent studies have shown that the corona may either attenuate or exacerbate reactive oxygen species (ROS) production, depending on its protein composition and conformational dynamics [62]. For example, in zebrafish liver cells, protein corona formation was found to influence NP-induced oxidative stress and disrupt glycolipid metabolism [63]. ...

The role of protein corona in advancing plasma proteomics

... It is noteworthy that the superior performance of PtdChos alone compared to Molecular Sauce 1 could be attributed to interactions between the small molecules in the mixture, which may have lowered the effective concentration of PtdChos (for example, the interactions between PtdChos and triglycerides) 68,69 . Mass spectrometry workflow and the type of data analysis have a critical influence on proteomics outcomes in general 9,70-73 , as well as in the specific field of protein corona research 56,57,74 . For instance, our recent study demonstrated that identical corona-coated polystyrene NPs analyzed by different mass spectrometry centers resulted in a wide range of quantified proteins, varying from 235 to 1430 (5.1 fold increase as compared to plasma alone) 56 . ...

Standardizing Protein Corona Characterization in Nanomedicine: A Multicenter Study to Enhance Reproducibility and Data Homogeneity
  • Citing Article
  • August 2024

Nano Letters

... This technology has been widely applied in tissue engineering due to its ability to precisely control the deposition of reagents. Leveraging these advantages, numerous cardiovascular devices have been bioprinted to achieve structural complexity and enhanced functionality [8,[73][74][75]. Strategies to bioprint cardiac patches can vary based on the bioprinting modalities as well as bioinks used for printing. ...

Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins

... Diabetic wounds rank among the most prevalent complications associated with diabetes, causing severe pain and high mortality in patients [1][2][3]. Growth factor-based treatment strategies have shown effective therapeutic effects for diabetic wounds, mainly relying on the capability to regulate cellular proliferation, stimulate angiogenesis, and repair tissues [4][5][6][7]. These growth factors include platelet-derived growth factor (PDGF), fibroblast growth factor-7 (FGF-7), vascular endothelial growth factor (VEGF), etc. ...

Sex-specific nanomedicine- and biomaterials-based therapies of chronic wounds
  • Citing Article
  • April 2024

Nature Reviews Bioengineering

... 13 Consequently, there is an urgent need to develop a standardized protocol for protein corona analysis to reduce data heterogeneity and facilitate comparability across studies. 13,14 Our previous research indicates that major disparities in the characterization of the protein corona composition are primarily due to variations in sample preparation protocols, LC-MS workflows, and data processing. 13 We also revealed that harmonizing database search and data processing can significantly reduce the observed heterogeneity among core facilities. ...

Multi-omics exploration of biomolecular corona in nanomedicine therapeutics and diagnostics
  • Citing Article
  • April 2024

... The protein corona was prepared on the polystyrene NPs (PSNPs) according to the used procedure in recent studies. [12,29] It is noteworthy that we used PSNPs due to our extensive experience in optimizing the parameters involved in the formation of a pure protein corona, ensuring highly accurate and reproducible MS results. Full details on the PSNP optimization and characterization for protein corona formation are available in our recent publications. ...

Mass spectrometry-based top-down proteomics in nanomedicine: proteoform-specific measurement of protein corona
  • Citing Preprint
  • March 2024

... hard-corona-bearing NPs can be isolated, and their corona protein composition can be determined [10,11]. Along with the proteins of the hard corona, which are tightly bound to the NPs' surface, there are proteins with low affinity to the surface, which form an extremely variable layer-the "soft corona", the composition of which easily changes under the influence of environmental factors [9]. ...

Protein Corona Composition of Gold Nanocatalysts
  • Citing Article
  • March 2024

ACS Pharmacology & Translational Science